(Q44695040)

5 December 2017

title

The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models (English)

1 reference

5 December 2017

1 reference

Elizabeth Kudlacz

1

1 reference

5 December 2017

Bret Perry

2

1 reference

5 December 2017

Perry Sawyer

3

1 reference

5 December 2017

Maryrose Conklyn

4

1 reference

5 December 2017

Sandra McCurdy

5

1 reference

5 December 2017

William Brissette

6

1 reference

5 December 2017

Mark Flanagan And

7

1 reference

5 December 2017

Paul Changelian

8

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

American Journal of Transplantation

5 December 2017

published in

1 reference

5 December 2017

volume

4

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

51-57

1 reference

Cytokine receptor signaling pathways

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

The role of Jak3 in lymphoid development, activation, and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

Optimal analysis of composite cytokine responses during alloreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

Interleukin 15: biology and relevance to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

Interleukin-15 gene transcripts are present in rejecting islet allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00281.X

10.1046/J.1600-6143.2003.00281.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference